We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$217M
AUM Growth
-$5.69M
Cap. Flow
-$14.7M
Cap. Flow %
-6.79%
Top 10 Hldgs %
44.19%
Holding
671
New
37
Increased
83
Reduced
179
Closed
34

Similar funds

AlphaMark Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, AlphaMark Advisors held 671 positions worth $217M, down 2.6% from $223M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

AlphaMark Advisors withdrew a net $14.7M in Q2 2023, closing 34 positions and reducing 179 holdings. Its most notable exit was Edwards Lifesciences, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, AlphaMark Advisors opened a new position in Albemarle worth $530K.

  • AlphaMark Advisors's largest Q2 2023 buy was Albemarle: 2,377 shares worth $530K.
  • AlphaMark Advisors added most to Janus Henderson AAA CLO ETF in Q2 2023, an estimated $1.42M increase.
  • AlphaMark Advisors's biggest Q2 2023 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $1.96M.
  • AlphaMark Advisors fully exited Edwards Lifesciences in Q2 2023, selling an estimated $2.23M.
  • AlphaMark Advisors's ten largest holdings make up 44% of its $217M portfolio in Q2 2023.
  • AlphaMark Advisors opened 37 new positions and closed 34 in Q2 2023.
  • AlphaMark Advisors's portfolio value fell 2.6% quarter-over-quarter to $217M.

Based on AlphaMark Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.